137 related articles for article (PubMed ID: 18221200)
1. Protein kinase C pharmacology: perspectives on therapeutic potentials as antidementic and cognitive agents.
Sun MK; Alkon DL
Recent Pat CNS Drug Discov; 2006 Jun; 1(2):147-56. PubMed ID: 18221200
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of protein kinase C activators: cognition-enhancing and antidementic therapeutics.
Sun MK; Alkon DL
Pharmacol Ther; 2010 Jul; 127(1):66-77. PubMed ID: 20382181
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase C isozymes for the treatment of dementias.
Sun MK; Alkon DL
Adv Pharmacol; 2012; 64():273-302. PubMed ID: 22840750
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C isozymes: memory therapeutic potential.
Sun MK; Alkon DL
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):541-52. PubMed ID: 16266287
[TBL] [Abstract][Full Text] [Related]
5. The "memory kinases": roles of PKC isoforms in signal processing and memory formation.
Sun MK; Alkon DL
Prog Mol Biol Transl Sci; 2014; 122():31-59. PubMed ID: 24484697
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C activators as synaptogenic and memory therapeutics.
Sun MK; Alkon DL
Arch Pharm (Weinheim); 2009 Dec; 342(12):689-98. PubMed ID: 19899099
[TBL] [Abstract][Full Text] [Related]
7. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease.
Alkon DL; Sun MK; Nelson TJ
Trends Pharmacol Sci; 2007 Feb; 28(2):51-60. PubMed ID: 17218018
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of chronic bryostatin-1 and alpha-tocopherol on spatial learning and memory in rats.
Sun MK; Alkon DL
Eur J Pharmacol; 2008 Apr; 584(2-3):328-37. PubMed ID: 18313045
[TBL] [Abstract][Full Text] [Related]
9. [Protein kinase C].
Matsushima H; Shimohama S
Nihon Rinsho; 1995 May; 53(5):1282-6. PubMed ID: 7602792
[TBL] [Abstract][Full Text] [Related]
10. Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?
Talman V; Pascale A; Jäntti M; Amadio M; Tuominen RK
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):149-60. PubMed ID: 27001133
[TBL] [Abstract][Full Text] [Related]
11. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
Clark EA; Leach KL; Trojanowski JQ; Lee VM
Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
[TBL] [Abstract][Full Text] [Related]
12. Bryostatin-1: pharmacology and therapeutic potential as a CNS drug.
Sun MK; Alkon DL
CNS Drug Rev; 2006; 12(1):1-8. PubMed ID: 16834754
[TBL] [Abstract][Full Text] [Related]
13. A role for protein kinase C in associative learning.
Olds JL; Alkon DL
New Biol; 1991 Jan; 3(1):27-35. PubMed ID: 2039766
[TBL] [Abstract][Full Text] [Related]
14. Role of protein kinase C isozymes in activation of human immunodeficiency virus type 1 in chronically infected promonocytic cells: evidence against a role of PKC beta 1.
Kim CH; Lim SJ; Gollapudi S; Gupta S
Biochem Biophys Res Commun; 1994 Feb; 199(1):292-7. PubMed ID: 8123026
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels.
Moore P; White J; Christiansen V; Grammas P
Neurosci Lett; 1998 Sep; 254(1):29-32. PubMed ID: 9780084
[TBL] [Abstract][Full Text] [Related]
16. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair.
Nelson TJ; Sun MK; Hongpaisan J; Alkon DL
Eur J Pharmacol; 2008 May; 585(1):76-87. PubMed ID: 18402935
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.
Matsushima H; Shimohama S; Chachin M; Taniguchi T; Kimura J
J Neurochem; 1996 Jul; 67(1):317-23. PubMed ID: 8667008
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C-epsilon protects PC12 cells against methamphetamine-induced death: possible involvement of suppression of glutamate receptor.
Uemura K; Aki T; Yamaguchi K; Yoshida Ki
Life Sci; 2003 Feb; 72(14):1595-607. PubMed ID: 12551748
[TBL] [Abstract][Full Text] [Related]
19. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.
Wang HY; Pisano MR; Friedman E
Neurobiol Aging; 1994; 15(3):293-8. PubMed ID: 7936052
[TBL] [Abstract][Full Text] [Related]
20. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.
Shimohama S; Narita M; Matsushima H; Kimura J; Kameyama M; Hagiwara M; Hidaka H; Taniguchi T
Neurology; 1993 Jul; 43(7):1407-13. PubMed ID: 8327146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
